UnitedHealth Group (NYSE:UNH) Stock Price Expected to Rise, KeyCorp Analyst Says

Key Points

• KeyCorp analysts raised their price target for UnitedHealth Group from $350.00 to $400.00, indicating a potential upside of 7.83% from its current stock price.
• Overall, the stock has a consensus rating of "Hold" with an average target price of $367.27, while 16 analysts rated it as a Buy.
• In its last earnings report, UnitedHealth Group reported $4.08 EPS, missing analysts' expectations of $4.45 EPS, while seeing a 12.9% year-over-year revenue increase.

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target upped by research analysts at KeyCorp from $350.00 to $400.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an "overweight" rating on the healthcare conglomerate's stock. KeyCorp's price target suggests a potential upside of 7.83% from the stock's current price.

Other analysts have also recently issued research reports about the stock. Truist Financial upped their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research note on Tuesday, September 9th. Zacks Research raised shares of UnitedHealth Group from a "strong sell" rating to a "hold" rating in a research note on Monday. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. JPMorgan Chase & Co. reduced their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Finally, Bank of America raised their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday, August 18th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $367.27.

UnitedHealth Group Price Performance

Shares of UNH opened at $370.96 on Wednesday. The firm has a market capitalization of $335.96 billion, a PE ratio of 16.07, a price-to-earnings-growth ratio of 2.33 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The company's fifty day moving average price is $311.44 and its 200-day moving average price is $352.42.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts predict that UnitedHealth Group will post 29.54 EPS for the current year.

Institutional Trading of UnitedHealth Group

A number of institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Geode Capital Management LLC raised its holdings in UnitedHealth Group by 3.3% in the second quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate's stock valued at $6,624,411,000 after acquiring an additional 675,075 shares in the last quarter. Norges Bank acquired a new stake in UnitedHealth Group in the second quarter valued at $3,837,207,000. Finally, Dodge & Cox raised its holdings in shares of UnitedHealth Group by 117.7% during the second quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate's stock worth $2,729,912,000 after purchasing an additional 4,730,192 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.